Article Information
History
- November 15, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Carlos Oltmanns1,2,3,4,#,
- Birgit Bremer1,3,
- Laura Kusche1,
- Per Stål6,
- Robin Zenlander7,
- Jan Tauwaldt1,2,3,4,
- Ingvar Rydén8,
- Peter Påhlsson8,*,
- Markus Cornberg1,2,3,4,5,* and
- Heiner Wedemeyer1,3,5,*
- 1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH), Hannover, Germany
- 2Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH). Hannover, Germany
- 3Cluster of Excellence Resolving Infection Susceptibility (RESIST; EXC 2155), Hannover Medical School, Hannover, Germany
- 4TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH). Hannover, Germany
- 5German Centre for Infection Research (DZIF), partner site Hannover-Braunschweig, Germany
- 6Department of Medicine, Huddinge, Karolinska Institutet; and Division of Hepatology, Department of Upper GI diseases, Karolinska University Hospital; Stockholm, Sweden
- 7Department of Clinical Chemistry, Karolinska University Hospital; Department of Laboratory Medicine, Karolinska Institutet; and Department of Medicine, Huddinge, Karolinska Institutet; Stockholm, Sweden
- 8Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
- ↵#Corresponding author; email: oltmanns.carlos{at}mh-hannover.de
↵* contributed equally
Posted November 15, 2023.
Fibrosis and liver inflammation are key regulators of α1-acid glycoprotein fucosylation
